uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted March 4, 2016

Federal Court Shuts Down Seller of Supplement Promoted for Herpes

On February 26, 2016, a federal court ordered dietary supplement company Viruxo LLC to stop selling its product Virux, which was promoted to treat herpes.

The company claimed its product, which contained a combination of lysine, zinc and other ingredients, could treat herpes outbreaks. Statements made on its website included "New Herpes Treatment! Cure for Herpes Outbreaks" and "Viruxo Anti-Viral Support ...Never Have A Herpes Outbreak Again!"

(See's Review of Lysine Supplements for tests of related products).

The FDA issued Viruxo a warning letter in 2011, for making these claims. Although the company responded that it would address these and other violations noted in the warning letter, it continued to market the product as a treatment for herpes.

The injunction issued against Viruxo requires to the company to remove all drug claims from its website and to notify the FDA at least 14 days before the creation of a new website.

See Related Warnings:

FDA Warns: Beware of Bogus STD Products

Maker of Herbal Supplements Sold on eBay, Amazon and Other Websites Shut Down

Company Ordered to Stop Making and Selling Supplements

Supplement Maker Ordered to Stop Selling Products

To read the FDA's press release, use the link below.